Skip to main content
Didem Saygin, MD, Rheumatology, Chicago, IL

Didem Saygin MD


Assistant Professor of Medicine

Join to View Full Profile
  • Rush University 1611 W Harrison StSuite 510Chicago, IL 60612

  • Phone+1 312-563-2928

Dr. Saygin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Didem Saygin is a rheumatologist at Rush University in Chicago, Illinois. She completed her internal medicine residency training at University of Pittsburgh and rheumatology fellowship training at University of Chicago. She is a clinician-researcher conducting outcome measure and epidemiological studies in inflammatory myopathies (myositis) and rheumatic interstitial lung diseases. Additionally, she serves on the board of International Myositis Society (iMyoS) and holds positions at various committees on American College of Rheumatology (ACR), International Myositis Assessment and Clinical Studies (IMACS) and Myositis International Health and Research Collaborative Alliance (MIHRA).

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Rheumatology, 2020 - 2022
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2017 - 2020
  • Istanbul University Fom
    Istanbul University FomClass of 2014

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2026
  • PA State Medical License
    PA State Medical License 2022 - 2024
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Distinguished Fellow Award American College of Rheumatology

Publications & Presentations

PubMed

Press Mentions

  • Low Geographic, Racial Diversity Persists in Myositis Clinical Trials Despite Recent Improvements
    Low Geographic, Racial Diversity Persists in Myositis Clinical Trials Despite Recent ImprovementsApril 2nd, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: